Piper Sandler Cuts Oscar Health (NYSE:OSCR) Price Target to $18.00

Oscar Health (NYSE:OSCR) had its price objective lowered by Piper Sandler from $25.00 to $18.00 in a research report released on Monday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the stock.

A number of other analysts have also recently weighed in on the stock. Wall Street Zen cut shares of Oscar Health from a “buy” rating to a “hold” rating in a report on Sunday. Wells Fargo & Company cut shares of Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Oscar Health currently has a consensus rating of “Hold” and a consensus target price of $16.50.

Oscar Health Stock Down 3.7%

OSCR stock opened at $14.14 on Monday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The firm’s 50-day simple moving average is $13.95 and its 200 day simple moving average is $14.52. The stock has a market cap of $3.60 billion, a PE ratio of -706.65 and a beta of 1.73.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The business had revenue of $3 billion for the quarter, compared to analysts’ expectations of $2.87 billion. During the same quarter last year, the company earned $0.62 EPS. The company’s revenue for the quarter was up 42.2% compared to the same quarter last year. As a group, sell-side analysts predict that Oscar Health will post 0.69 EPS for the current year.

Insider Buying and Selling at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now owns 64,512 shares of the company’s stock, valued at $1,059,932.16. The trade was a 27.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 24.39% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Oscar Health

Several hedge funds have recently made changes to their positions in the business. Hsbc Holdings PLC grew its stake in shares of Oscar Health by 2.7% in the 1st quarter. Hsbc Holdings PLC now owns 24,113 shares of the company’s stock worth $313,000 after purchasing an additional 632 shares during the last quarter. Tempus Wealth Planning LLC grew its stake in shares of Oscar Health by 6.7% in the 1st quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company’s stock worth $189,000 after purchasing an additional 906 shares during the last quarter. Focus Partners Wealth grew its stake in shares of Oscar Health by 1.8% in the 1st quarter. Focus Partners Wealth now owns 55,158 shares of the company’s stock worth $723,000 after purchasing an additional 949 shares during the last quarter. Xponance Inc. grew its stake in shares of Oscar Health by 7.1% in the 1st quarter. Xponance Inc. now owns 15,423 shares of the company’s stock worth $202,000 after purchasing an additional 1,029 shares during the last quarter. Finally, CWM LLC grew its stake in shares of Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after purchasing an additional 1,078 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.